Effects of GnRH antagonist treatment on follicular development and angiogenesis in the primate ovary

Journal of Endocrinology

Volumn 183, Issue 1, 2004, Pages 1-17

  Taylor, P D ^a,b   Hillier, S G ^b   Fraser, H M ^a,b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN ANTAGONIST; GONADOTROPIN; MESSENGER RNA; TEVERELIX; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; ENDOTHELIUM CELL; FEMALE; FOLLICULAR PHASE; GONADOTROPIN RELEASE; GRANULOSA CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VIVO STUDY; MARMOSET; MORPHOLOGICAL TRAIT; NONHUMAN; OVARY FOLLICLE ATRESIA; OVARY FOLLICLE CELL; OVARY FOLLICLE DEVELOPMENT; OVULATION; PARACRINE SIGNALING; PRIMATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; THECA CELL; TISSUE SECTION; VASCULARIZATION;

ANIMALS; CALLITHRIX; CELL PROLIFERATION; CELL SIZE; ENDOTHELIAL CELLS; FEMALE; FOLLICULAR PHASE; GONADOTROPIN-RELEASING HORMONE; HORMONE ANTAGONISTS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES; OVARIAN FOLLICLE; OVARY; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 12344267805     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05685     Document Type: Article

References (39)

1. Barboni B, Turriani M, Galeati G, Spinaci M, Bacci ML, Forni M & Mattioli M 2000 Vascular endothelial growth factor production in growing pig antral follicles. Biology of Reproduction 63 858-864.
2. Christenson LK & Stouffer RL 1997 Follicle-stimulating hormone and luteinizing hormone/chorionic gonadotropin stimulation of vascular endothelial growth factor production by macaque granulosa cells from pre- and periovulatory follicles. Journal of Clinical Endocrinology and Metabolism 82 2135-2142.
3. Deghenghi R, Boutignon F, Wuthrich P & Lenaerts V 1993 Antarelix (EP 24332) a novel water soluble LHRH antagonist. Biomedical Pharmacotherapy 47 107-110.
4. Dickson SE & Fraser HM 2000 Inhibition of early luteal angiogenesis by gonadotropin-releasing hormone antagonist treatment in the primate. Journal of Clinical Endocrinology and Metabolism 85 2339-2344.
5. Ditkoff EC, Cassidenti DL, Paulson RJ, Sauer MV, Paul WL, Rivier J, Yen SS & Lobo RA 1991 The gonadotropin-releasing hormone antagonist (Nal-Glu) acutely blocks the luteinizing hormone surge but allows for resumption of folliculogenesis in normal women. American Journal of Obstetrics and Gynecology 165 1811-1817.
6. Durlinger AL, Kramer P, Karels B, Grootegoed JA, Uilenbroek JT & Themmen AP 2000 Apoptotic and proliferative changes during induced atresia of pre-ovulatory follicles in the rat. Human Reproduction 15 2504-2511.
7. Fluker MR, Marshall LA, Monroe SE & Jaffe RB 1991 Variable ovarian response to gonadotropin-releasing hormone antagonist-induced gonadotropin deprivation during different phases of the menstrual cycle. Journal of Clinical Endocrinology and Metabolism 72 912-919.
8. Fraser HM & Wulff C 2001 Angiogenesis in the primate ovary. Reproduction, Fertility and Development 13 557-566.
9. Fraser HM, Abbott M, Laird NC, McNeilly AS, Nestor JJ Jr & Vickery BH 1986 Effects of an LH-releasing hormone antagonist on the secretion of LH, FSH, prolactin and ovarian steroids at different stages of the luteal phase in the stumptailed macaque (Macaca arctoides). Journal of Endocrinology 111 83-90.
10. Fraser HM, Dickson SE, Morris KD, Erickson GF & Lunn SF 1999a The effect of the angiogenesis inhibitor TNP-470 on luteal establishment and function in the primate. Human Reproduction 14 2054-2060.
11. Fraser HM, Groome NP & McNeilly AS 1999b Follicle-stimulating hormone-inhibin B interactions during the follicular phase of the primate menstrual cycle revealed by gonadotropin-releasing hormone antagonist and antiestrogen treatment. Journal of Clinical Endocrinology and Metabolism 84 1365-1369.
12. Fraser HM, Dickson SE, Lunn SF, Wulff C, Morris KD, Carroll VA & Bicknell R 2000 Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 141 995-1000.
13. Gilchrist RB, Wicherck M, Heistermann M, Nayudu PL & Hodges JK 2001 Changes in follicle-stimulating hormone and follicle populations during the ovarian cycle of the common marmoset. Biology of Reproduction 64 127-135.
14. Hall JE, Bhatta N, Adams JM, Rivier JE, Vale WW & Crowley WF Jr 1991 Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human. Journal of Clinical Endocrinology and Metabolism 72 993-1000.
15. Hazzard TM, Molskness TA, Chaffin CL & Stouffer RL 1999 Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Molecular Human Reproduction 5 1115-1121.
16. Huirne JA, Lambalk CB, van Loenen AC, Schats R, Hompes PG, Fauser BC & Macklon NS 2004 Contemporary pharmacological manipulation in assisted reproduction. Drugs 64 297-322.
17. Karnitis VJ, Townson DH, Friedman CI & Danforth DR 1994 Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropin-releasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis. Journal of Clinical Endocrinology and Metabolism 79 91-97.
18. Koos RD 1995 Increased expression of vascular endothelial growth/permeability factor in the rat ovary following an ovulatory gonadotropin stimulus: potential roles in follicle rupture. Biology of Reproduction 32 1426-1435.
19. McAnulty PA 1994 Marmoset care and reproduction. In The Marmoset - Role in Pharmaceutical Development, pp. 7-12. Ed. JS Fowler. Ipswich: Pharmaco LSR.
20. Mann GE, Lamming GE & Fray MD 1995 Plasma oestradiol and progesterone during early pregnancy in the cow and the effects of treatment with buserelin. Animal Reproduction Science 37 121-131.
21. Martinez-Chequer JC, Stouffer RL, Hazzard TM, Patton PE & Molskness TA 2003 Insulin-like growth factors-1 and -2, but not hypoxia, synergize with gonadotropin hormone to promote vascular endothelial growth factor - A secretion by monkey granulosa cells from preovulatory follicles. Biology of Reproduction 68 1112-1118.
22. Neeman M, Abramovitch R, Schiffenbauer YS & Tempel C 1997 Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. International Journal of Experimental Pathology 78 57-70.
23. Nelson LR, Fujimoto VY, Jaffe RB & Monroe SE 1995 Suppression of follicular phase pituitary-gonadal function by a potent new gonadotropin-releasing hormone antagonist with reduced histamine-releasing properties (ganirelix). Fertility and Sterility 63 963-969.
24. Oberye JJ, Mannaerts BM, Huisman JA & Timmer CJ 1999 Pharmacokinetic and pharmacodynamic characteristics of ganirelix (Antagon/Orgalutran). Part II. Dose-proportionality and gonadotropin suppression after multiple doses of ganirelix in healthy female volunteers. Fertility and Sterility 72 1006-1012.
25. Phillips HS, Hains J, Leung DW & Ferrara N 1990 Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127 965-967.
26. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N & Zeleznik AJ 1992 Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology 131 254-260.
27. Redmer DA, Doraiswamy V, Bortnem BJ, Fisher K, Jablonka-Shariff A, Grazul-Bilska AT & Reynolds LP 2001 Evidence for a role of capillary pericytes in vascular growth of the developing ovine corpus luteum. Biology of Reproduction 65 879-889.
28. Sharkey AM, Day K, McPherson A, Malik S, Licence D, Smith SK & Charnock-Jones DS 2000 Vascular endothelial growth factor expression in human endometrium is regulated by hypoxia. Journal of Clinical Endocrinology and Metabolism 85 402-409.
29. Shweiki D, Itin A, Soffer D & Keshet E 1992 Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 339 843-845.
30. Shweiki D, Itin A, Neufeld G, Gitay-Goren H & Keshet E 1993 Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. Journal of Clinical Investigation 91 2235-2243.
31. Tsafriri A & Braw RH 1984 Experimental approaches to atresia in mammals. Oxford Reviews of Reproductive Biology 6 226-265.
32. Wulff C, Dickson SE, Duncan WC & Fraser HM 2001a Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Human Reproduction 16 2515-2524.
33. Wulff C, Wiegand SJ, Saunders PT, Scobie GA & Fraser HM 2001b Angiogenesis during follicular development in the primate and its inhibition by treatment with truncated Flt-1-Fc (vascular endothelial growth factor Trap(A40)). Endocrinology 142 3244-3254.
34. Wulff C, Wilson H, Rudge JS, Wiegand SJ, Lunn SF & Fraser HM 2001c Luteal angiogenesis: prevention and intervention by treatment with vascular endothelial growth factor trap (A40). Journal of Clinical Endocrinology and Metabolism 86 3377-3386.
35. Wulff C, Wilson H, Wiegand SJ, Rudge JS & Fraser HM 2002 Prevention of thecal angiogenesis, antral follicular growth, and ovulation in the primate by treatment with vascular endothelial growth factor Trap R1R2. Endocrinology 143 2797-2807.
36. Zeleznik AJ, Schuler HM & Reichert LE Jr 1981 Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology 109 356-362.
37. Zimmermann RC, Xiao E, Husami N, Sauer MV, Lobo R, Kitajewski J & Ferin M 2001 Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. Journal of Clinical Endocrinology and Metabolism 86 768-772.
38. Zimmermann RC, Xiao E, Bohlen P & Ferin M 2002 Administration of antivascular endothelial growth factor receptor 2 antibody in the early follicular phase delays follicular selection and development in the rhesus monkey. Endocrinology 143 2496-2502.
39. Zimmermann RC, Hartman T, Kavic S, Pauli SA, Bohlen P, Sauer MV & Kitajewski J 2003 Vascular endothelial growth factor receptor 2-mediated angiogenesis is essential for gonadotropin-dependent follicle development. Journal of Clinical Investigation 112 659-669.